Blackstone Inc’s Alimera Sciences ALIM Stock Holding History

Blackstone Inc’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,612	Closed	-$45K	–	614
2021 Q3	$45K	Buy	+10,612	New	+$74K	﹤0.01%	586

Other funds holding ALIM

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Blackstone Inc's ALIM Position: Q4 2021 in Review

Blackstone Inc sold out of Alimera Sciences (ALIM) in Q4 2021, closing a stake of 10,612 shares — an estimated $45K sold.

Blackstone Inc first reported a position in ALIM in Q3 2021 and held it in 1 quarter. The position peaked at $45K in Q3 2021. 21 funds tracked by Wall St. Rank hold ALIM as of Q4 2021.

Blackstone Inc reported no remaining Alimera Sciences position as of Q4 2021 after selling out during the quarter.
Blackstone Inc sold 10,612 Alimera Sciences shares in Q4 2021, an estimated $45K.
Blackstone Inc first reported a position in Alimera Sciences in Q3 2021 and held it in 1 quarter.
Blackstone Inc's Alimera Sciences position peaked at $45K in Q3 2021.
21 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2021.

Based on Blackstone Inc's 13F filing for Q4 2021, filed 14 Feb 2022.